NYSE:VAPO

Stock Analysis Report

Executive Summary

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide.

Snowflake

Fundamentals

Imperfect balance sheet with concerning outlook.

Risks

  • Vapotherm has significant price volatility in the past 3 months.

Similar Companies

Share Price & News

How has Vapotherm's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

13.9%

NYSE:VAPO

1.5%

US Medical Equipment

0.8%

US Market


1 Year Return

n/a

NYSE:VAPO

9.7%

US Medical Equipment

1.9%

US Market

No trading data on VAPO.

No trading data on VAPO.


Share holder returns

VAPOIndustryMarket
7 Day13.9%1.5%0.8%
30 Day-29.2%0.7%3.4%
90 Day-53.8%2.4%2.1%
1 Yearn/a10.6%9.7%4.2%1.9%
3 Yearn/a70.2%65.0%46.7%37.2%
5 Yearn/a136.0%109.1%62.3%44.5%

Price Volatility Vs. Market

How volatile is Vapotherm's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Vapotherm undervalued based on future cash flows and its price relative to the stock market?

5.8x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Vapotherm to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Vapotherm to establish if it is available at substantial discount.


Price Based on Earnings

Vapotherm is loss making, we can't compare its value to the US Medical Equipment industry average.

Vapotherm is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Vapotherm, we can't assess if its growth is good value.


Price Based on Value of Assets

Vapotherm is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Vapotherm expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

2.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Vapotherm's revenue is expected to grow by 18.1% yearly, however this is not considered high growth (20% yearly).

Vapotherm is not considered high growth as it is expected to be loss making for the next 1-3 years.

Vapotherm's revenue growth is expected to exceed the United States of America market average.

Unable to compare Vapotherm's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.

Unable to compare Vapotherm's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Vapotherm will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Vapotherm performed over the past 5 years?

-31.0%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Vapotherm does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.

Unable to compare Vapotherm's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Vapotherm's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Vapotherm has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Vapotherm has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Vapotherm improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Vapotherm's financial position?


Financial Position Analysis

Vapotherm is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Vapotherm's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Vapotherm's level of debt (152.7%) compared to net worth is high (greater than 40%).

Unable to establish if Vapotherm's debt level has increased without past 5-year debt data.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 1.5x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Vapotherm has less than a year of cash runway based on current free cash flow.

Vapotherm has less than a year of cash runway if free cash flow continues to grow at historical rates of 17.1% each year.


Next Steps

Dividend

What is Vapotherm's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Vapotherm's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Vapotherm's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Vapotherm has not reported any payouts.

Unable to verify if Vapotherm's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Vapotherm has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of Vapotherm's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of Vapotherm's salary, the management and board of directors tenure and is there insider trading?

6.7yrs

Average management tenure


CEO

Joe Army (55yo)

7.3yrs

Tenure

US$625,334

Compensation

Mr. Joseph F. Army, also known as Joe, CPA has been the Chief Executive Officer and President of Vapotherm, Inc. since June 26, 2012. Mr. Army served as the Chief Executive Officer and President of Salient ...


CEO Compensation Analysis

Joe's remuneration is lower than average for companies of similar size in United States of America.

Joe's compensation has increased whilst company is loss making.


Management Age and Tenure

6.7yrs

Average Tenure

55yo

Average Age

The average tenure for the Vapotherm management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

6.7yrs

Average Tenure

65yo

Average Age

The tenure for the Vapotherm board of directors is about average.


Insider Trading

More shares have been bought than sold by Vapotherm individual insiders in the past 3 months.


Recent Insider Transactions

BuyUS$173,56413 Sep 19
3x5 Partners
EntityCompany
Shares20,000
Max PriceUS$8.68
BuyUS$95,38709 Sep 19
Elizabeth Weatherman
EntityIndividual
Role
Member of the Board of Directors
Director
Shares8,382
Max PriceUS$11.38
BuyUS$63,18906 Sep 19
Elizabeth Weatherman
EntityIndividual
Role
Member of the Board of Directors
Director
Shares5,988
Max PriceUS$10.93
BuyUS$31,02006 Sep 19
John Landry
EntityIndividual
Role
Chief Financial Officer
CFO, VP
Shares3,000
Max PriceUS$10.34
BuyUS$20,38006 Sep 19
John Coolidge
EntityIndividual
Role
Chief Operating Officer
Vice President of Operations
Shares2,000
Max PriceUS$10.19
BuyUS$100,00506 Sep 19
Joseph Army
EntityIndividual
Role
Chief Executive Officer
CEO, President & Director
Shares10,000
Max PriceUS$10.00
BuyUS$146,33014 Aug 19
Michael McQueen
EntityIndividual
Shares10,000
Max PriceUS$14.64
BuyUS$435,00007 Aug 19
Elizabeth Weatherman
EntityIndividual
Role
Member of the Board of Directors
Director
Shares30,000
Max PriceUS$14.50
BuyUS$143,43005 Aug 19
3x5 Partners
EntityCompany
Shares10,000
Max PriceUS$14.34
BuyUS$214,26802 Aug 19
Joseph Army
EntityIndividual
Role
Chief Executive Officer
CEO, President & Director
Shares15,000
Max PriceUS$14.28
BuyUS$1,295,00020 Nov 18
Gilde Healthcare Partners B.V.
EntityCompany
Shares92,500
Max PriceUS$14.00

Ownership Breakdown


Management Team

  • Bill Niland

    • Tenure: 0yrs
  • Joe Army (55yo)

    CEO, President & Director

    • Tenure: 7.3yrs
    • Compensation: US$625.33k
  • John Coolidge (58yo)

    Vice President of Operations

    • Tenure: 5.5yrs
    • Compensation: US$283.28k
  • John Landry (46yo)

    CFO, VP

    • Tenure: 7.1yrs
    • Compensation: US$277.31k
  • Lise Halpern (60yo)

    Vice President of Marketing

    • Tenure: 6.7yrs
  • Lindsay Becker (34yo)

    Vice President of Human Resources

    • Tenure: 3.3yrs
  • Anthony Haagen

    Vice President of Legal & Compliance

    • Tenure: 0yrs

Board Members

  • J. Armstrong (80yo)

    Director

    • Tenure: 11.9yrs
    • Compensation: US$15.40k
  • Jim Liken (70yo)

    Chairman of The Board

    • Tenure: 6.9yrs
    • Compensation: US$20.02k
  • Craig Reynolds (70yo)

    Director

    • Tenure: 9.1yrs
    • Compensation: US$15.42k
  • Bess Weatherman (59yo)

    Director

    • Tenure: 1.9yrs
    • Compensation: US$20.38k
  • Marina Hahn (61yo)

    Director

    • Tenure: 1.9yrs
    • Compensation: US$20.07k
  • Tony Arnerich (69yo)

    Director

    • Tenure: 6.5yrs
    • Compensation: US$19.66k
  • Geoff Pardo (47yo)

    Director

    • Tenure: 5.6yrs
    • Compensation: US$19.99k
  • Joe Army (55yo)

    CEO, President & Director

    • Tenure: 7.3yrs
    • Compensation: US$625.33k

Company Information

Vapotherm, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Vapotherm, Inc.
  • Ticker: VAPO
  • Exchange: NYSE
  • Founded: 1993
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$204.190m
  • Shares outstanding: 20.60m
  • Website: https://www.vapotherm.com

Number of Employees


Location

  • Vapotherm, Inc.
  • 100 Domain Drive
  • Exeter
  • New Hampshire
  • 3833
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VAPONYSE (New York Stock Exchange)YesCommon StockUSUSDNov 2018
VA21DB (Deutsche Boerse AG)YesCommon StockDEEURNov 2018

Biography

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory d ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 01:36
End of Day Share Price2019/09/17 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.